XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2025
Apr. 30, 2024
Current assets:    
Cash and cash equivalents $ 10,026 $ 3,151
Accounts receivable, net 1,626 796
Contract assets 478 18
Inventory 3,949 4,831
Other current assets 752 1,747
Total current assets 16,831 10,543
Property and equipment, net 3,589 3,443
Intangibles, net 3,523 3,622
Right-of-use assets, net 1,772 2,405
Restricted cash, long-term 154 154
Goodwill 8,537 8,537
Total assets 34,406 28,704
Current liabilities:    
Accounts payable 637 3,366
Earnout payable 350 1,130
Accrued expenses 2,240 1,787
Right-of-use liabilities, current portion 1,115 774
Contract liabilities 302
Total current liabilities 4,342 7,359
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 950 1,798
Total liabilities 5,495 9,360
Commitments and contingencies (Note 14)
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 200,000,000 shares, issued 170,790,707 shares and 61,352,731 shares, respectively; outstanding 170,003,230 shares and 61,264,714 shares, respectively 170 61
Treasury stock, at cost; 787,477 and 88,017 shares, respectively (1,018) (369)
Additional paid-in capital 352,468 327,276
Accumulated deficit (322,664) (307,579)
Accumulated other comprehensive loss (45) (45)
Total shareholders’ equity 28,911 19,344
Total liabilities and shareholders’ equity $ 34,406 $ 28,704